Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis

Gynecologic Oncology

Volumn 140, Issue 1, 2016, Pages 184-190

  Secord, Angeles Alvarez ^a,b   Hasselblad, Vic ^b   Von Gruenigen, Vivian E ^c   Gehrig, Paola A ^d   Modesitt, Susan C ^e   Bae Jump, Victoria ^d   Havrilesky, Laura J ^a  

^a DUKE CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c SUMMA HEALTH SYSTEM   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Body mass index; Endometrial cancer; Mortality; Obesity; Survival

Indexed keywords

BODY MASS; CANCER MORTALITY; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL ASSESSMENT; CLINICAL EVALUATION; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MEDICAL INFORMATION; MEDLINE; META ANALYSIS; OBESITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; CLINICAL TRIAL; ENDOMETRIUM TUMOR; MORTALITY; MULTICENTER STUDY;

BODY MASS INDEX; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS;

EID: 84951737216     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.10.020     Document Type: Review

References (44)

1. R. Kaaks, A. Lukanova, and M.S. Kurzer Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review Cancer Epidemiol. Biomark. Prev. 11 12 2002 1531 1543
2. A.G. Renehan, M. Tyson, M. Egger, R.F. Heller, and M. Zwahlen Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 2008 569 578
3. American Cancer Society Cancer Facts & Figures 2015 2015 American Cancer Society Atlanta
4. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N. Engl. J. Med. 348 17 2003 1625 1638
5. H. Arem, and M.L. Irwin Obesity and endometrial cancer survival: a systematic review Int. J. Obes. 37 5 2013 634 639
6. Methods guide for effectiveness and comparative effectiveness reviews AHRQ Publication No. 10 (14)-EHC063-EF January 2014 Agency for Healthcare Research and Quality Rockville, MD (Chapters available at: www.effectivehealthcare.ahrq.gov. [cited 2015 June 16, 2015])
7. G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, and et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 7650 2008 924 926
8. H. Arem, R. Chlebowski, M.L. Stefanick, G. Anderson, J. Wactawski-Wende, S. Sims, and et al. Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative Gynecol. Oncol. 128 2 2013 181 186
9. V. Hasselblad, A.G. Stead, and W. Galke Analysis of coarsely grouped data from the lognormal distribution J. Am. Stat. Assoc. 75 372 1980 771 778
10. V. Hasselblad Meta-analysis of multitreatment studies Med. Decis. Mak. 18 1 1998 37 43
11. Inc. SI SAS/STAT ® 9.2 User's Guide 2009 (Cary, NC)
12. H. Arem, Y. Park, C. Pelser, R. Ballard-Barbash, M.L. Irwin, A. Hollenbeck, and et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients J. Natl. Cancer Inst. 105 5 2013 342 349
13. T. Bjorge, T. Stocks, A. Lukanova, S. Tretli, R. Selmer, J. Manjer, and et al. Metabolic syndrome and endometrial carcinoma Am. J. Epidemiol. 171 8 2010 892 902
14. V.M. Chia, P.A. Newcomb, A. Trentham-Dietz, and J.M. Hampton Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis Int. J. Gynecol. Cancer 17 2 2007 441 446
15. G.K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer, D. Bull, and et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study BMJ 335 7630 2007 1134
16. V.E. Von Gruenigen, C. Tian, H. Frasure, S. Waggoner, H. Keys, and R.R. Barakat Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: a Gynecologic Oncology Group study Cancer 107 12 2006 2786 2791
17. S.C. Modesitt, C. Tian, R. Kryscio, J.T. Thigpen, M.E. Randall, H.H. Gallion, and et al. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study Gynecol. Oncol. 105 1 2007 59 65
18. O. Akbayir, A. Corbacioglu Esmer, C. Numanoglu, B.P. Cilesiz Goksedef, A. Akca, L.V. Bakir, and et al. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer Arch. Gynecol. Obstet. 286 5 2012 1269 1276
19. E.J. Crosbie, C. Roberts, W. Qian, A.M. Swart, H.C. Kitchener, and A.G. Renehan Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial Eur. J. Cancer 48 6 2012 853 864
20. E.J. Gates, L. Hirschfield, R.P. Matthews, and O.W. Yap Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium J. Natl. Med. Assoc. 98 11 2006 1814 1822
21. N.H. Jeong, J.M. Lee, J.K. Lee, J.W. Kim, C.H. Cho, S.M. Kim, and et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women Gynecol. Oncol. 118 1 2010 24 28
22. J. Kodama, N. Seki, Y. Ojima, K. Nakamura, A. Hongo, and Y. Hiramatsu Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women Int. J. Gynaecol. Obstet. 91 2 2005 151 156
23. F. Martra, C. Kunos, H. Gibbons, P. Zola, L. Galletto, R. DeBernardo, and et al. Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study Am. J. Obstet. Gynecol. 198 1 2008 89 (e1-8)
24. K.K. Mauland, J. Trovik, E. Wik, M.B. Raeder, T.S. Njolstad, I.M. Stefansson, and et al. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer Br. J. Cancer 104 6 2011 921 926
25. B. Rabischong, D. Larrain, M. Canis, G. Le Bouedec, C. Pomel, K. Jardon, and et al. Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study J. Minim. Invasive Gynecol. 18 5 2011 589 596
26. K. Munstedt, M. Wagner, U. Kullmer, A. Hackethal, and F.E. Franke Influence of body mass index on prognosis in gynecological malignancies Cancer Causes Control 19 9 2008 909 916
27. S.M. Temkin, J.C. Pezzullo, M. Hellmann, Y.C. Lee, and O. Abulafia Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am. J. Clin. Oncol. 30 1 2007 8 14
28. J.J. Griggs, P.B. Mangu, H. Anderson, E.P. Balaban, J.J. Dignam, W.M. Hryniuk, and et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline J. Clin. Oncol. 30 13 2012 1553 1561
29. B. Pichon, S. Thureau, G. Delpon, I. Barillot, and M.A. Mahé Obesity and radiation: technical difficulties, toxicity and efficacy Cancer Radiother. 17 5-6 2013 543 548
30. L.L. Lin, L. Hertan, R. Rengan, and T. B-KK Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance Int. J. Radiat. Oncol. Biol. Phys. 83 2012 670 675
31. D.E. Amundson, S. Djurkovic, and G.N. Matwiyoff The obesity paradox Crit. Care Clin. 26 4 2010 583 596
32. A. Berrington de Gonzalez, P. Hartge, J.R. Cerhan, A.J. Flint, L. Hannan, M.I. RJ, and et al. Body-mass index and mortality among 1.46 million white adults N. Engl. J. Med. 363 23 2010 2211 2219
33. K.F. Adams, A. Schatzkin, T.B. Harris, V. Kipnis, T. Mouw, R. Ballard-Barbash, A. Hollenbeck, and M.F. Leitzmann Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old N. Engl. J. Med. 355 8 2006 763 778
34. K.M. Flegal, B.K. Kit, H. Orpana, and B.I. Graubard Association of mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis JAMA 309 1 2013 71 82
35. J.R. Robbins, O.H. Gayar, M. Zaki, M. Mahan, T. Buekers, and M.A. Elshaikh Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer Gynecol. Oncol. 131 3 2013 593 597
36. K.K. Ward, N.R. Shah, C.C. Saenz, M.T. McHale, E.A. Alvarez, and S.C. Plaxe Cardiovascular disease is the leading cause of death among endometrial cancer patients Gynecol. Oncol. 126 2 2012 176 179
37. A.N. Fader, L.N. Arriba, H.E. Frasure, and V.E. von Gruenigen Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship Gynecol. Oncol. 114 1 2009 121 127
38. M.L. Irwin, and S.T. Mayne Impact of nutrition and exercise on cancer survival Cancer J. 14 6 2008 435 441
39. M.L. McCarroll, S. Armbruster, H.E. Frasure, M.D. Gothard, K.M. Gil, M.B. Kavanagh, and et al. Self-efficacy, quality of life, and weight loss in overweight/obese endometrial cancer survivors (SUCCEED): a randomized controlled trial Gynecol. Oncol. 132 2 2014 397 402
40. A.R. Folsom, S.A. Kaye, J.D. Potter, and R.J. Prineas Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study Cancer Res. 49 23 1989 6828 6831
41. M.J. Khandekar, P. Cohen, and B.M. Spiegelman Molecular mechanisms of cancer development in obesity Nat. Rev. Cancer 11 12 2011 886 895
42. A. Berg, E.A. Hoivik, S. Mjos, F. Holst, H.M. Werner, I.L. Tangen, and et al. Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients Oncotarget 6 2 Ja20 2015 1327 1339
43. A. Dellas, G. Jundt, G. Sartorius, M. Schneider, and H. Moch Combined PTEN and p27kip1 protein expression patterns are associated with obesity and prognosis in endometrial carcinomas Clin. Cancer Res. 15 7 2009 2456 2462
44. S.N. Westin, Z. Ju, R.R. Broaddus, C. Krakstad, J. Li, N. Pal, and et al. PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrialcancer patients Mol. Oncol. 9 8 2015 1694 1703